Cargando…
FXYD2 antisense oligonucleotide provides an efficient approach for long-lasting relief of chronic peripheral pain
Chronic pain, whether of inflammatory or neuropathic origin, affects about 18% of the population of developed countries, and most current treatments are only moderately effective and/or cause serious side effects. Therefore, the development of novel therapeutic approaches still represents a major ch...
Autores principales: | Derre, Alexandre, Soler, Noelian, Billoux, Valentine, Benizri, Sebastien, Vialet, Brune, Rivat, Cyril, Barthélémy, Philippe, Carroll, Patrick, Pattyn, Alexandre, Venteo, Stephanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243811/ https://www.ncbi.nlm.nih.gov/pubmed/37154155 http://dx.doi.org/10.1172/jci.insight.161246 |
Ejemplares similares
-
Fxyd2 regulates Aδ- and C-fiber mechanosensitivity and is required for the maintenance of neuropathic pain
por: Ventéo, Stéphanie, et al.
Publicado: (2016) -
Lipid oligonucleotides as a new strategy for tackling the antibiotic resistance
por: Kauss, Tina, et al.
Publicado: (2020) -
Regulation of the Na,K-ATPase Gamma-Subunit FXYD2 by Runx1 and Ret Signaling in Normal and Injured Non-Peptidergic Nociceptive Sensory Neurons
por: Ventéo, Stéphanie, et al.
Publicado: (2012) -
Antisense Oligonucleotide-Based Therapeutic against Menin for Triple-Negative Breast Cancer Treatment
por: Nguyen, Dang Tan, et al.
Publicado: (2021) -
What FXYDs fix
por: Habeck, Michael, et al.
Publicado: (2021)